Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Alfiya Nesterova"'
Autor:
Mafalda Oliveira, Denys Pominchuck, Zbigniew Nowecki, Erika Hamilton, Yaroslav Kulyaba, Timur Andabekov, Yevhen Hotko, Tamar Melkadze, Gia Nemsadze, Patrick Neven, Yuriy Semegen, Vladmir Vladmirov, Claudio Zamagni, Hannelore Denys, Frederic Forget, Zsolt Horvath, Alfiya Nesterova, Maxine Bennett, Bistra Kirova, Teresa Klinowska, Justin Lindemann, Delphine Lissa, Alastair Mathewson, Christopher Morrow, Zuzana Traugottova, Ruaan Van Zyl, Ekaterine Arkania
Publikováno v:
Cancer Research. 83:GS3-02
Background Camizestrant (C), a next-generation oral selective estrogen receptor (ER) antagonist and degrader (ngSERD) has shown promising clinical activity in ER+ breast cancer (BC) in the Phase 1 SERENA-1 study1,2 with a dose-dependent safety profil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12e1c7074b8ccc605160741e8e23510e
https://doi.org/10.1158/1538-7445.sabcs22-gs3-02
https://doi.org/10.1158/1538-7445.sabcs22-gs3-02
